PubMed Health⌕ Search

Biomedical subjects

W C Hughes

Publications and source records attributed to W C Hughes.

8 recordsLinked to original sources
PubMed1999

Managed care, meet community support: ten reasons to include direct support services in every behavioral health plan.

In this article, the performance of community support programs over three decades is assessed through a review of the professional literature, with emphasis on clinical outcomes, cost-effectiveness, and consumer satisfaction. The author argues that for managed behavioral health organizations to serve disabled customers adequately, community support is required. Ten field-tested reasons to include community support services in every behavioral health plan are presented. The author concludes that social workers are uniquely qualified to adapt proven interventions from model community support programs to the mission of managed behavioral health organizations, with the potential to remedy problems of access, continuity, and accountability in providing treatment for serious and persistent mental illness.

Behavior Therapy↗
PubMed1979

Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients.

A study was carried out in which 135 mildly or moderately depressed outpatients were randomly allocated to one of five groups receiving six weeks' treatment weith antidepressant drugs. The groups received a tricyclic antidepressant (trimipramine; mean dose 106 mg at night) or a monoamine oxidase inhibitor (MAOI) (phenelzine or isocarboxazid; mean doses 45 and 32 mg/day respectively), or a combination of the two (phenelzine plus trimipramine or isocarboxazid plus trimipramine). Various scales were used to measure depression before and at one, three, and six weeks of treatment, and results were assessed blindly. The tricyclic antidepressant was found to be consistently superior to the MAOIs and the combined treatments. Some differential indicators of response to the various antidepressants were found--for example, patients with initial complaints of dizziness, suicidal ideas, irritability, and insomnia and a longer duration of illness were more likely to respond to trimipramine--but these were of only modest significance. Side effects were not troublesome in any group. It is concluded that neither MAOIs nor MAOIs combined with tricyclic antidepressants are the treatment of first choice in unselected outpatients with mild or moderate depression.

Adult↗
PubMed1976

A controlled comparison of flupenthixol and amitriptyline in depressed outpatients.

Sixty depressed outpatients were allocated to treatment with either amitriptyline (75-225 mg/day) or flupenthixol (1-5-4-5 mg/day) in flexible dosage for six weeks under double-blind procedures. Various objective and subjective assessments were carried out before and after one, three, and six weeks of treatment. Twenty-three patients completed the course of amitriptyline and 28 the course of flupenthixol. Almost all variables improved significantly over time, irrespective of drug. On most ratings there were no significant differences between the two drugs, but the trends favoured flupenthixol. In particular, flupenthixol lessened anxiety scores more than amitriptyline. Unwanted effects were few and not troublesome except in two patients receiving amitriptyline. Flupenthixol, in low dosage, is a useful alternative antidepressant for depressed outpatients.

Adult↗